Triple-negative breast cancer does not behave the same way in every patient. A population-based study in Sweden following 8,298 women diagnosed between 2007 and 2021 describes a particularly vulnerable subgroup: those who relapse within the first two years. That group has both more aggressive tumours and a more disadvantaged social profile, according to the findings published in Breast Cancer Research and Treatment.
What was known
Triple-negative disease is a heterogeneous subtype, lacking oestrogen and progesterone receptors and HER2, with a higher risk of early relapse than other subtypes. Clinical practice already separates early from late relapse, but broad population-level descriptions combining tumour features, treatments received and patients’ sociodemographic situation within a single national cohort were missing.
What this work adds
A retrospective cohort built from linked Swedish population-based registers, including women with non-metastatic triple-negative breast cancer diagnosed between 2007 and 2021. They were classified into three groups by time to distant relapse or death: rapid (24 months or less), late (more than 24 months) and event-free at last follow-up. Tumour characteristics, comorbidity, treatments and sociodemographic variables were compared, with multivariable logistic regression and sensitivity analyses restricted to regions with complete relapse data.
Main results
Of the 8,298 patients, 15% had rapid relapse, 18% late relapse and 67% remained event-free at last follow-up. Rapid relapse was associated with older age, larger tumours, nodal involvement, more advanced stage and more visceral and multi-organ metastases. These patients were less likely to have received adjuvant systemic therapy or radiotherapy, and more likely to have undergone mastectomy. Sociodemographic differences also appeared: early relapse was more frequent among women who were single or widowed, had lower education or lower household income. Survival was substantially worse in the rapid-relapse group than in the late-relapse and event-free groups.
What it means
The study outlines two phenotypes within triple-negative disease. Rapid relapse defines a vulnerable population with aggressive biology, early dissemination, poorer survival and accumulated social disadvantage; late relapse behaves as an intermediate phenotype. Separating the two could refine risk stratification, inform treatment decisions and support more personalised follow-up.
A view from the breast unit
The finding invites units to treat equity as part of quality of care: to check whether patients with less education or living alone reach adjuvant treatment and radiotherapy as reliably as others, and whether follow-up pathways retain them. These are factors a breast unit can measure and act on, although this Swedish study does not allow its specific figures to be transferred to the Spanish setting.
Reference: Sarathchandra S, Nyqvist-Streng J, Sahlberg E, Einbeigi Z, Helou K, Kovács A, et al. Sociodemographic and clinicopathologic features associated with rapid relapse in triple-negative breast cancer: a Swedish nationwide registry-based study. Breast Cancer Research and Treatment, 2026. DOI
